Results: 1-3 |
Results: 3

Authors: Burtness, B Belker, M Stoltz, M Peccerillo, KM Lamb, LA Chmael, SE McKeon, A Clark, MB Winship, J Marsh, JC Pizzorno, G DeVita, VT
Citation: B. Burtness et al., A phase I study of the antimetabolite (E)-2 '-fluoromethylene-2 '-deoxycytidine (MDL 101,731) administered as a twice-weekly infusion, CANCER J, 6(5), 2000, pp. 309-315

Authors: Schwartz, GK Ilson, D Saltz, L O'Reilly, E Tong, W Maslak, P Werner, J Perkins, P Stoltz, M Kelsen, D
Citation: Gk. Schwartz et al., Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma, J CL ONCOL, 19(7), 2000, pp. 1985-1992

Authors: Russell, T Stoltz, M Weir, S
Citation: T. Russell et al., Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers, CLIN PHARM, 64(6), 1998, pp. 612-621
Risultati: 1-3 |